ReviewThe journal of prevention of Alzheimer's disease2025

Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research.

Eric E Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.